PENTABASE A/S

CVR30197852

Stamdata

Navn
PENTABASE A/S
Adresse
Petersmindevej 1A, 5000, Odense C
Stiftelsesdato
8. jan. 2007
Antal ansatte
37
Lokationer (P-enheder)
1Se lokationer
Hjemmeside
https://pentabase.com/
Facebook
5Base
LinkedIn
pentabase-a-s
Branche
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Hold øje med PENTABASE A/S

Få en email, når vi registrerer ændringer i regnskaber, ejerskab eller ledelse. Så slipper du for selv at tjekke virksomheden.
Gratis konto

Beskrivelse

PentaBase er en dansk, videnskabsdrevet IVD-virksomhed, der udvikler og producerer sensitive og specifikke PCR-assays, diagnostiske workflows og PCR-analyser ved hjælp af proprietær INA® DNA-analog-teknologi til onkologi- og hæmatologidiagnostik.

PentaBase udvikler og producerer innovative PCR-løsninger og leverer genetiske analyser og tjenester til præcis detektion og monitorering af genetiske biomarkører, herunder CE-IVD-certificerede onkologi- og hæmatologiassays.

Egen beskrivelse på virk.dk

PentaBase A/S is a knowledge-driven organization committed to maintaining the highest scientific and ethical standards. We exclusively develop and provide products and services where there is strong clinical evidence supporting the relevance of the underlying biomarkers. Our mission is to advance precision medicine by delivering innovative molecular diagnostic solutions that improve patient stratification, treatment selection, and disease monitoring. Our activities are centered around proprietary DNA technologies and a comprehensive portfolio of molecular diagnostic products supporting the detection, characterization, and monitoring of cancer-related genetic and epigenetic biomarkers. In addition, we collaborate with research institutions, hospitals, and industrial partners by making our proprietary DNA platform technologies available for research and development within molecular diagnostics and life sciences. During 2025, PentaBase continued to strengthen its strategic focus on oncology diagnostics while advancing the commercialization of recently launched technologies and expanding collaborations with international clinical and research partners. Significant efforts have also been dedicated to further developing the Company's proprietary technology platforms and protecting its intellectual property portfolio. Management is satisfied with the Company's development during 2025. The financial performance improved significantly compared with the previous year, reflecting increased commercial activity, continued cost discipline, and a stronger operational foundation for future growth. Management continues to integrate environmental and social responsibility into the Company's decision-making processes. Our facilities include a rooftop solar energy installation, electric vehicle charging stations, and initiatives encouraging sustainable transportation, including cycling and the transition to electric vehicles. Together with customers and suppliers, we continue working to reduce our environmental footprint through improved recycling initiatives and by minimizing the use of plastic and polystyrene packaging materials.

Produkter & services

Onkologi IVD-PCR-assays · Hæmatologi IVD-PCR-assays · Specialtilpassede oligonukleotider · EpiDirect® MGMT Methylation qPCR Assay · MicroSight® MSI · PlentiPlex™ MYD88, CE IVD · EpiDirect® MLH1 · Genetiske analyser og tjenester · INA®-teknologi

Brancher

Sundhedsvæsen · Produktion

Kundetyper

Kliniske laboratorier · Sundhedspersonale · Kvalificeret laboratoriepersonale · Forsknings- og kliniske laboratorier

Økonomi

Selskabsregnskab
Regnskabsperiode
2025kr.
Bruttofortjeneste
10.461.737
Driftsresultat
-5.712.008
Resultat før skat
-1.177.610
Årets resultat
-892.430
Samlede aktiver
55.274.233
Egenkapital
53.182.584
Gns. ansatte
24
2017–2025

Lås regnskabshistorikken op

Datapublica Risk Score

Låst
Vurderer risikoen for økonomiske problemer ud fra virksomhedens regnskaber, historik og relationer.
Virksomhedens score
0 · Lav100 · Høj

Det indgår i vurderingen

  • Økonomi

  • Regnskaber og historik

  • Ejere og ledelse

  • Virksomhed og relationer

Standard: Score og risikoniveauPro: Også detaljeret forklaring af faktorerne

Kontakt

Fra cvr.dk

Virksomhed
3696****Vis hele
bo*****@pentabase.comVis hele

Fra pentabase.com

Hovedkontakt
in**@pentabase.comVis hele
Virksomhed
+45 36 96 ** **Vis hele

Gazelle

Henter gazelle-status…

Børsen Gazelle er Dagbladet Børsens kåring. Datapublica er ikke tilknyttet Børsen. Beregnede statusser er Datapublicas egen analyse af offentlige CVR-regnskabsdata.

Ledelse og roller

Anne Gerhart-HinesRoller
Bestyrelse
TitlerBESTYRELSESMEDLEM
Hans Christian RohdeRoller
Bestyrelse
TitlerFORMAND
Søren BoeRoller
Bestyrelse
TitlerBESTYRELSESMEDLEM
Torben Storgaard GuldbergRoller
Bestyrelse
TitlerBESTYRELSESMEDLEM
Ulf Bech ChristensenRoller
BestyrelseDirektion
TitlerBESTYRELSESMEDLEM • ADM. DIR.

Revisor

BDO Statsautoriseret RevisionspartnerselskabRevisorMikkel AalykkeRolleState Authorised Public AccountantFra30. jun. 2026
BDO Statsautoriseret RevisionspartnerselskabRevisor—Rolle—Fra30. jun. 2026

Legale ejere

Ejerandel66,67–89,99 %Stemmeandel66,67 %Fra29. mar. 2020
Ejerandel5–9,99 %Stemmeandel0 %Fra19. dec. 2025

Dattervirksomheder

Ejerandel100 %Stemmeandel100 %Fra5. jun. 2026

Ultimative ejere

Ulf Bech Christensen
Ejerskab gennem
Ukendt ejerandel